Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 99% | 2236.48 | 179 / 180 | 93% | 61.64 | 400 / 430 |
lung | 100% | 6365.19 | 578 / 578 | 92% | 58.18 | 1057 / 1155 |
thymus | 100% | 3537.48 | 651 / 653 | 89% | 39.14 | 536 / 605 |
esophagus | 97% | 2196.78 | 1397 / 1445 | 91% | 62.09 | 167 / 183 |
breast | 100% | 3364.90 | 457 / 459 | 88% | 60.99 | 984 / 1118 |
uterus | 100% | 5081.52 | 170 / 170 | 87% | 94.96 | 399 / 459 |
bladder | 100% | 2473.00 | 21 / 21 | 82% | 60.25 | 414 / 504 |
intestine | 99% | 3198.38 | 961 / 966 | 80% | 34.70 | 420 / 527 |
liver | 100% | 2894.32 | 225 / 226 | 75% | 28.52 | 303 / 406 |
stomach | 88% | 1776.96 | 317 / 359 | 84% | 47.67 | 241 / 286 |
skin | 97% | 1760.23 | 1750 / 1809 | 73% | 72.07 | 343 / 472 |
kidney | 100% | 1996.55 | 89 / 89 | 68% | 46.86 | 610 / 901 |
prostate | 99% | 3192.53 | 243 / 245 | 48% | 11.51 | 240 / 502 |
adrenal gland | 95% | 1245.13 | 245 / 258 | 12% | 3.88 | 27 / 230 |
pancreas | 20% | 161.22 | 65 / 328 | 82% | 32.29 | 146 / 178 |
adipose | 100% | 3963.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 4505.17 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2365.14 | 1332 / 1335 | 0% | 0 | 0 / 0 |
brain | 42% | 620.79 | 1114 / 2642 | 56% | 36.73 | 398 / 705 |
tonsil | 0% | 0 | 0 / 0 | 96% | 118.56 | 43 / 45 |
lymph node | 0% | 0 | 0 / 0 | 93% | 167.10 | 27 / 29 |
peripheral blood | 82% | 2337.74 | 764 / 929 | 0% | 0 | 0 / 0 |
heart | 80% | 1054.23 | 689 / 861 | 0% | 0 | 0 / 0 |
muscle | 40% | 365.59 | 321 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 14% | 10.95 | 11 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051715 | Biological process | cytolysis in another organism |
GO_0140639 | Biological process | positive regulation of pyroptotic inflammatory response |
GO_0032703 | Biological process | negative regulation of interleukin-2 production |
GO_0050860 | Biological process | negative regulation of T cell receptor signaling pathway |
GO_0045087 | Biological process | innate immune response |
GO_0042832 | Biological process | defense response to protozoan |
GO_0072665 | Biological process | protein localization to vacuole |
GO_0051607 | Biological process | defense response to virus |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_0071347 | Biological process | cellular response to interleukin-1 |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0050848 | Biological process | regulation of calcium-mediated signaling |
GO_0042742 | Biological process | defense response to bacterium |
GO_0160075 | Biological process | non-canonical inflammasome complex assembly |
GO_1900025 | Biological process | negative regulation of substrate adhesion-dependent cell spreading |
GO_1903077 | Biological process | negative regulation of protein localization to plasma membrane |
GO_1903076 | Biological process | regulation of protein localization to plasma membrane |
GO_0071346 | Biological process | cellular response to type II interferon |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0012506 | Cellular component | vesicle membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0000139 | Cellular component | Golgi membrane |
GO_0015629 | Cellular component | actin cytoskeleton |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0106139 | Cellular component | symbiont cell surface |
GO_0030659 | Cellular component | cytoplasmic vesicle membrane |
GO_0019003 | Molecular function | GDP binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0030507 | Molecular function | spectrin binding |
GO_0051879 | Molecular function | Hsp90 protein binding |
GO_0019955 | Molecular function | cytokine binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003925 | Molecular function | G protein activity |
GO_0005525 | Molecular function | GTP binding |
GO_0004382 | Molecular function | GDP phosphatase activity |
GO_0001530 | Molecular function | lipopolysaccharide binding |
GO_0005515 | Molecular function | protein binding |
GO_0003779 | Molecular function | actin binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | GBP1 |
Protein name | Guanylate binding protein 1 Guanylate-binding protein 1 Guanylate-binding protein 1 (EC 3.6.1.-) (EC 3.6.5.-) (GTP-binding protein 1) (GBP-1) (HuGBP-1) (hGBP1) (Guanine nucleotide-binding protein 1) (Interferon-induced guanylate-binding protein 1) |
Synonyms | |
Description | FUNCTION: Interferon (IFN)-inducible GTPase that plays important roles in innate immunity against a diverse range of bacterial, viral and protozoan pathogens . Hydrolyzes GTP to GMP in two consecutive cleavage reactions: GTP is first hydrolyzed to GDP and then to GMP in a processive manner . Following infection, recruited to the pathogen-containing vacuoles or vacuole-escaped bacteria and promotes both inflammasome assembly and autophagy . Acts as a positive regulator of inflammasome assembly by facilitating the detection of inflammasome ligands from pathogens . Involved in the lysis of pathogen-containing vacuoles, releasing pathogens into the cytosol (By similarity). Following pathogen release in the cytosol, forms a protein coat in a GTPase-dependent manner that encapsulates pathogens and promotes the detection of ligands by pattern recognition receptors . Plays a key role in inflammasome assembly in response to infection by Gram-negative bacteria: following pathogen release in the cytosol, forms a protein coat that encapsulates Gram-negative bacteria and directly binds to lipopolysaccharide (LPS), disrupting the O-antigen barrier and unmasking lipid A that is that detected by the non-canonical inflammasome effector CASP4/CASP11 . Also promotes recruitment of proteins that mediate bacterial cytolysis, leading to release double-stranded DNA (dsDNA) that activates the AIM2 inflammasome . Involved in autophagy by regulating bacteriolytic peptide generation via its interaction with ubiquitin-binding protein SQSTM1, which delivers monoubiquitinated proteins to autolysosomes for the generation of bacteriolytic peptides (By similarity). Confers protection to several pathogens, including the bacterial pathogens L.monocytogenes and M.bovis BCG as well as the protozoan pathogen T.gondii . Exhibits antiviral activity against influenza virus . . |
Accessions | A0A348GSI6 P32455 ENST00000370473.5 A0A7P0TAZ1 ENST00000681280.1 |